Home Biosimilar Antibodies Transmembrane Transporters CD markers antibody Ocrelizumab (Anti-CD20) For research use only.
Not for use in humans.

Ocrelizumab (Anti-CD20)

Synonyms:

Ocrelizumab (Anti-CD20) is a recombinant humanized monoclonal IgG1 antibody that selectively targets CD20 antigen present on B-cells. It is used to treat relapsing remitting multiple sclerosis. MW:145.5 KD.

Ocrelizumab (Anti-CD20)

Purity & Quality Control

Batch: A256101 Purity: 99% Protein concentration: 4.56mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective CD markers Inhibitors

Biological Activity

Description Ocrelizumab (Anti-CD20) is a recombinant humanized monoclonal IgG1 antibody that selectively targets CD20 antigen present on B-cells. It is used to treat relapsing remitting multiple sclerosis. MW:145.5 KD.

Product Details

CAS No. 637334-45-3
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Ocrelizumab (Anti-CD20) | Ocrelizumab (Anti-CD20) supplier | purchase Ocrelizumab (Anti-CD20) | Ocrelizumab (Anti-CD20) cost | Ocrelizumab (Anti-CD20) manufacturer | order Ocrelizumab (Anti-CD20) | Ocrelizumab (Anti-CD20) distributor